Literature DB >> 21530494

Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis.

Wen-bin Liu1, Lin Ao, Zhi-hong Cui, Zi-yuan Zhou, Yan-hong Zhou, Xiao-yan Yuan, Yun-long Xiang, Jia Cao, Jin-yi Liu.   

Abstract

A defective ratio between DNA damage and repair may result in the occurrence of a malignant phenotype. Previous studies have found that many genetic alterations in DNA repair genes occur frequently in lung cancer. However, the epigenetic mechanisms underlying this tumorigenesis are not clear. Herein, we have used a chemical-induced rat lung carcinogenesis model to study the evolution of methylation alterations of DNA repair genes BRCA1, ERCC1, XRCC1, and MLH1. Methylation-specific PCR and immunohistochemistry were used to analyze gene methylation status and protein expression during the progression of lung carcinogenesis. Promoter hypermethylation of BRCA1 was only detected in three samples of infiltrating carcinoma. CpG island hypermethylation of ERCC1, XRCC1, and MLH1 was found to increase gradually throughout lung carcinogenesis progression. Both the prevalence of at least one methylated gene and the average number of methylated genes were heightened in squamous metaplasia and dysplasia compared with normal tissue and hyperplasia, and was further increased in carcinoma in situ (CIS) and infiltrating carcinoma. Immunohistochemical analysis showed that BRCA1 and MLH1 protein expression decreased progressively during the stages of lung carcinogenesis, whereas ERCC1 and XRCC1 expression were only found in later stages. Although methylation levels were elevated for ERCC1 and XRCC1 during carcinogenesis, an inverse correlation with protein expression was found only for BRCA1 and MLH1. These results suggest that a continuous accumulation of DNA repair gene hypermethylation and the consequent protein alterations might be a vital molecular mechanism during the process of multistep chemical-induced rat lung carcinogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530494     DOI: 10.1016/j.bbrc.2011.04.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.

Authors:  Zi-Zhen Zhang; Yuan Jie Charles Liu; Xiao-Lu Yin; Ping Zhan; Yi Gu; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

2.  Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.

Authors:  Ishrat Mahjabeen; Kashif Ali; Xiaofeng Zhou; Mahmood Akhtar Kayani
Journal:  Tumour Biol       Date:  2014-03-13

Review 3.  DNA methyltransferases, DNA damage repair, and cancer.

Authors:  Bilian Jin; Keith D Robertson
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.

Authors:  W-b Liu; X Jiang; F Han; Y-h Li; H-q Chen; Y Liu; J Cao; J-y Liu
Journal:  Cell Death Dis       Date:  2013-10-24       Impact factor: 8.469

5.  Development of serous ovarian cancer is associated with the expression of homologous recombination pathway proteins.

Authors:  Qingqing Ye; Li Chen; Xiaolu Yin; Yuan Jie Charles Liu; Qunsheng Ji; Enfeng Zhao
Journal:  Pathol Oncol Res       Date:  2014-04-22       Impact factor: 3.201

6.  The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review.

Authors:  Yi Han; Kang Shi; Shi-Jie Zhou; Da-Ping Yu; Zhi-Dong Liu
Journal:  Onco Targets Ther       Date:  2016-08-16       Impact factor: 4.147

7.  Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation.

Authors:  Yui Terayama; Tetsuro Matsuura; Kiyokazu Ozaki
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 8.  [Advances of DNA methylation in early diagnosis of lung cancer].

Authors:  Xiaoming Qiu; Yanjie Qiao; Bin Liu; Yang Li; Jiacong You; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-04

9.  TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.

Authors:  Wen-bin Liu; Fei Han; Xiao Jiang; Hong-qiang Chen; Huan Zhao; Yong Liu; Yong-hong Li; Chuanshu Huang; Jia Cao; Jin-yi Liu
Journal:  Oncotarget       Date:  2015-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.